TABLE 1.
Conventional histology and clinical, etiological, anatomical and pathophysiological classification of patients
| C2 to C3 (N=5) (n=5/subject) | C4 to C5 (N=5) (n=5/subject) | ||
|---|---|---|---|
| S100 immunostaining | |||
| Presence of positive elements | N (% of subjects) | 5 (100.0) | 5 (100.0) |
| n (% of samples) | 25 (100.0) | 18 (75.0)* | |
| Nerve fibres per sample | |||
| None | n (% of samples) | 0 (0) | 6 (25.0)* |
| <2 | n (% of samples) | 11 (44.0) | 12 (50.0)* |
| 2–5 | n (% of samples) | 14 (56.0) | 6 (25.0)* |
| CD45 immunostaining | |||
| Presence of positive elements | N (% of subjects) | 5 (100.0) | 5 (100.0) |
| n (% of samples) | 24 (96.0) | 21 (87.5)* | |
| Nerve fibres per sample | |||
| None | n (% of samples) | 1 (4.0) | 3 (12.5)* |
| <2 | n (% of samples) | 13 (52.0) | 11 (45.8)* |
| 2–5 | n (% of samples) | 11 (44.0) | 10 (41.7)* |
*
One sample could not be interpreted. N Number of subjects; n Number of specimens